共 50 条
- [1] Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries MEDICAL SCIENCE MONITOR, 2011, 17 (04): : SR1 - SR13
- [5] Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries FRONTIERS IN PHARMACOLOGY, 2020, 11
- [7] Access barriers for central and eastern European countries to the Western European transport markets ACCESS TO EUROPEAN TRANSPORT MARKETS, 1996, : 107 - 117
- [8] Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 : S65 - S71
- [10] Child Well-Being in Central and Eastern European Countries (CEE) and the Commonwealth of Independent States (CIS) Child Indicators Research, 2008, 1 : 211 - 250